Patient-Reported Outcomes (PROs) With Consolidation Durvalumab Versus Placebo Following cCRT in Limited-Stage SCLC: ADRIATIC

Novello S., Cheng Y., Spigel D., Fang J., Chen Y., Zenke Y., ...More

JOURNAL OF THORACIC ONCOLOGY, no.10, 2024 (SCI-Expanded, Scopus)

• Publication Type: Article / Abstract
• Publication Date: 2024
• Journal Name: JOURNAL OF THORACIC ONCOLOGY
• Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, MEDLINE
• Istanbul University-Cerrahpasa Affiliated: Yes